We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
+9.5%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$1.76B
AUM Growth
+$16.7M
Cap. Flow
-$84.9M
Cap. Flow %
-4.82%
Top 10 Hldgs %
24.37%
Holding
275
New
15
Increased
54
Reduced
181
Closed
13

Top Buys

Rank Stock Value
1
RBA icon
RB Global
RBA
+$12.2M
2
PCRX icon
Pacira BioSciences
PCRX
+$12.2M
3
DOCS icon
Doximity
DOCS
+$8.19M
4
ESTA icon
Establishment Labs
ESTA
+$6.27M
5
COLB icon
Columbia Banking Systems
COLB
+$5M

Top Sells

Rank Stock Value
1
IAA
IAA, Inc. Common Stock
IAA
+$17.7M
2
MED icon
Medifast
MED
+$17.2M
3
ALBO
Albireo Pharma Inc
ALBO
+$11.1M
4
IWO icon
iShares Russell 2000 Growth ETF
IWO
+$6.11M
5
WNS
WNS Holdings
WNS
+$5.97M

Sector Composition

Rank Sector Weight
1 Healthcare 27.26%
2 Technology 26.93%
3 Industrials 17.12%
4 Consumer Discretionary 9.62%
5 Communication Services 6.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FNKO icon
201
Funko
FNKO
$346M
$1.71M 0.1%
181,463
-3,162
-2% -$32.8K
CLFD icon
202
Clearfield
CLFD
$391M
$1.7M 0.1%
+36,576
New +$2.36M
HLX icon
203
Helix Energy Solutions
HLX
$1.47B
$1.7M 0.1%
+219,185
New +$1.71M
PGNY icon
204
Progyny
PGNY
$2.18B
$1.69M 0.1%
52,681
+17,562
+50% +$580K
NESR
205
National Energy Services Reunited Corp
NESR
$3.61B
$1.68M 0.1%
320,043
-5,974
-2% -$39.4K
TECH icon
206
Bio-Techne
TECH
$11.2B
$1.67M 0.09%
22,454
-246
-1% -$19K
DLB icon
207
Dolby
DLB
$5.82B
$1.67M 0.09%
19,493
-155
-0.8% -$12.5K
CIEN icon
208
Ciena
CIEN
$54.9B
$1.65M 0.09%
31,442
-1,431
-4% -$71.4K
EW icon
209
Edwards Lifesciences
EW
$53B
$1.64M 0.09%
19,777
-219
-1% -$17.2K
AZTA icon
210
Azenta
AZTA
$1.54B
$1.61M 0.09%
36,185
-249
-0.7% -$12.3K
CERS icon
211
Cerus
CERS
$508M
$1.61M 0.09%
543,041
-11,751
-2% -$35.4K
IEX icon
212
IDEX
IEX
$17.2B
$1.6M 0.09%
6,910
-104
-1% -$23.6K
NIC icon
213
Nicolet Bankshares
NIC
$3.63B
$1.57M 0.09%
24,976
-19,883
-44% -$1.44M
JNJ icon
214
Johnson & Johnson
JNJ
$631B
$1.57M 0.09%
10,118
-89
-0.9% -$14.4K
EXEL icon
215
Exelixis
EXEL
$13.1B
$1.55M 0.09%
79,702
+3,889
+5% +$67.8K
TTC icon
216
Toro Company
TTC
$9.4B
$1.5M 0.09%
13,515
-2,538
-16% -$283K
OPTN
217
DELISTED
OptiNose
OPTN
$1.49M 0.08%
51,464
-2,503
-5% -$66.6K
SWI
218
DELISTED
SolarWinds Corporation Common Stock
SWI
$1.42M 0.08%
164,759
-7,733
-4% -$72K
KEX icon
219
Kirby Corp
KEX
$7B
$1.42M 0.08%
20,303
-8,115
-29% -$559K
MATX icon
220
Matsons
MATX
$6.24B
$1.41M 0.08%
23,553
-390
-2% -$25.1K
EBAY icon
221
eBay
EBAY
$47.9B
$1.37M 0.08%
30,884
-318
-1% -$14.6K
EOLS icon
222
Evolus
EOLS
$500M
$1.36M 0.08%
+160,594
New +$1.45M
CDW icon
223
CDW
CDW
$17.1B
$1.31M 0.07%
6,735
-445
-6% -$87.4K
KBR icon
224
KBR
KBR
$4.83B
$1.3M 0.07%
+23,587
New +$1.23M
RCKT icon
225
Rocket Pharmaceuticals
RCKT
$397M
$1.3M 0.07%
+75,675
New +$1.48M
7 8
9
10 11

Similar funds

RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
IL
Investure LLC Charlottesville, Virginia $2.04B AUM 15.91% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
SAM
Southeastern Asset Management Memphis, Tennessee $2.03B AUM 7.06% 1-Year Est. Return
AG
Avala Global New York $2.08B AUM 87.66% 1-Year Est. Return
TA
TruWealth Advisors Metairie, Louisiana $2.08B AUM 21.15% 1-Year Est. Return
ACP
Avantyr Capital Partners New York $2.08B AUM

Rice Hall James & Associates's Q1 2023 Portfolio in Review

As of Q1 2023, Rice Hall James & Associates held 275 positions worth $1.76B, up 0.96% from $1.74B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Rice Hall James & Associates withdrew a net $84.9M in Q1 2023, closing 13 positions and reducing 181 holdings. Its most notable exit was IAA, Inc. Common Stock, an estimated $17.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 26% a quarter earlier, followed by Technology and Industrials.

Against the trend, Rice Hall James & Associates opened a new position in RB Global worth $11.7M.

  • Rice Hall James & Associates's largest Q1 2023 buy was RB Global: 207,333 shares worth $11.7M.
  • Rice Hall James & Associates added most to Pacira BioSciences in Q1 2023, an estimated $12.2M increase.
  • Rice Hall James & Associates's biggest Q1 2023 reduction was Medifast, cutting an estimated $17.2M.
  • Rice Hall James & Associates fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $17.7M.
  • Rice Hall James & Associates's ten largest holdings make up 24% of its $1.76B portfolio in Q1 2023.
  • Rice Hall James & Associates opened 15 new positions and closed 13 in Q1 2023.
  • Rice Hall James & Associates's portfolio value rose 0.96% quarter-over-quarter to $1.76B.

Based on Rice Hall James & Associates's 13F filing for Q1 2023, filed 12 May 2023.